Show simple item record

dc.contributor.authorEccles, B
dc.contributor.authorCross, W
dc.contributor.authorRosario, D
dc.contributor.authorDoble, A
dc.contributor.authorParker, C
dc.contributor.authorLogue, John P
dc.contributor.authorLittle, L
dc.contributor.authorStanton, L
dc.contributor.authorBottomley, D
dc.date.accessioned2013-08-30T13:28:52Z
dc.date.available2013-08-30T13:28:52Z
dc.date.issued2013-08
dc.identifier.citationSABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer. 2013, 112 (3):330-7 BJU Inten_GB
dc.identifier.issn1464-410X
dc.identifier.pmid23826842
dc.identifier.doi10.1111/bju.12127
dc.identifier.urihttp://hdl.handle.net/10541/300430
dc.description.abstractTo determine the feasibility of a phase III randomised controlled trial of brachytherapy vs radical prostatectomy (RP) in men with low-intermediate risk localised prostate cancer.
dc.language.isoenen
dc.rightsArchived with thanks to BJU internationalen_GB
dc.titleSABRE 1 (Surgery Against Brachytherapy - a Randomised Evaluation): feasibility randomised controlled trial (RCT) of brachytherapy vs radical prostatectomy in low-intermediate risk clinically localised prostate cancer.en
dc.typeArticleen
dc.contributor.departmentUniversity of Southampton Clinical Trials Unit, Southampton.en_GB
dc.identifier.journalBJU Internationalen_GB
html.description.abstractTo determine the feasibility of a phase III randomised controlled trial of brachytherapy vs radical prostatectomy (RP) in men with low-intermediate risk localised prostate cancer.


This item appears in the following Collection(s)

Show simple item record